Search Results - "Osgood, L."

FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast Cancer by Wahby, Sakar, Fashoyin-Aje, Lola, Osgood, Christy L, Cheng, Joyce, Fiero, Mallorie H, Zhang, Lijun, Tang, Shenghui, Hamed, Salaheldin S, Song, Pengfei, Charlab, Rosane, Dorff, Sarah E, Ricks, Tiffany K, Barnett-Ringgold, Kimberly, Dinin, Jeannette, Goldberg, Kirsten B, Theoret, Marc R, Pazdur, Richard, Amiri-Kordestani, Laleh, Beaver, Julia A

“…On April 22, 2020, the FDA granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY; Immunomedics, Inc.) for the treatment of patients with…”
Get full text

Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies by Osgood, Marcey L.

“…Purpose of Review Aneurysmal subarachnoid hemorrhage remains a devastating disease process despite medical advances made over the past 3 decades. Much of the…”
Get full text

A New Preoperative Scoring System to Predict Difficulty of Laparoscopic Cholecystectomy and Risk of Conversion to Open Surgery by AbdelDayem, M., Osgood, L., Escofet, X., Farag, Maged

“…To develop a preoperative scoring model to assess difficulty of laparoscopic cholecystectomy (LC) and risk of conversion to open cholecystectomy (OC),…”
Get full text

FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer by Shah, Mirat, Osgood, Christy L, Amatya, Anup K, Fiero, Mallorie H, Pierce, William F, Nair, Abhilasha, Herz, Jonathan, Robertson, Kim J, Mixter, Bronwyn D, Tang, Shenghui, Pazdur, Richard, Beaver, Julia A, Amiri-Kordestani, Laleh

“…On July 26, 2021, the FDA granted approval to pembrolizumab in combination with chemotherapy for neoadjuvant treatment and then continued as a single agent for…”
Get full text

FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer by Narayan, Preeti, Osgood, Christy L, Singh, Harpreet, Chiu, Haw-Jyh, Ricks, Tiffany K, Chiu Yuen Chow, Edwin, Qiu, Junshan, Song, Pengfei, Yu, Jingyu, Namuswe, Frances, Guiterrez-Lugo, Maria, Hou, Sherry, Pierce, William F, Goldberg, Kirsten B, Tang, Shenghui, Amiri-Kordestani, Laleh, Theoret, Marc R, Pazdur, Richard, Beaver, Julia A

“…On December 20, 2019, the FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki [DS-8201a; T-DXd; tradename ENHERTU (Daiichi Sankyo)] for the…”
Get full text

FDA Approval Summary: Eribulin for Patients with Unresectable or Metastatic Liposarcoma Who Have Received a Prior Anthracycline-Containing Regimen by Osgood, Christy L, Chuk, Meredith K, Theoret, Marc R, Huang, Lan, He, Kun, Her, Leah, Keegan, Patricia, Pazdur, Richard

“…On January 28, 2016, the FDA approved eribulin (Halaven; Eisai Inc.) for the treatment of patients with unresectable or metastatic liposarcoma who have…”
Get full text

U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review by Arora, Shaily, Narayan, Preeti, Osgood, Christy L, Wedam, Suparna, Prowell, Tatiana M, Gao, Jennifer J, Shah, Mirat, Krol, Danielle, Wahby, Sakar, Royce, Melanie, Ghosh, Soma, Philip, Reena, Ison, Gwynn, Berman, Tara, Brus, Christina, Bloomquist, Erik W, Fiero, Mallorie H, Tang, Shenghui, Pazdur, Richard, Ibrahim, Amna, Amiri-Kordestani, Laleh, Beaver, Julia A

“…Over the last decade, the treatment of patients with breast cancer has been greatly impacted by the approval of multiple drugs and indications. This summary…”
Get full text

Municipal Clerks: Examining a Model of Job Satisfaction by Gordon, Victoria, Osgood, Jeffery L., Phillips, Jeremy

“…Using data from a survey of municipal clerks in the state of Illinois, this research tests a model of job satisfaction for municipal employees based on…”
Get full text

FDA Approval Summary: Capecitabine Labeling Update under Project Renewal by Agrawal, Sundeep, Lee, Clara, Pierce, William F, Everhart, Elizabeth, King-Ducre, Adriene, Royce, Melanie, Osgood, Christy L, Amiri-Kordestani, Laleh, Chiu, Haw-Jyh, Ricks, Tiffany K, Pan, Lili, Fourie Zirkelbach, Jeanne, Charlab, Rosane, Pacanowski, Michael, Kim, Tamy, Pazdur, Richard, Kluetz, Paul G, Gao, Jennifer J

“…On December 14, 2022, the U.S. Food and Drug Administration (FDA) approved revisions to the United States Prescribing Information (USPI) for capecitabine that…”
Get full text

Bulpitt in America: Presidential Approaches, Territorial Politics and the Field of Urban Policy by Savitch, H. V., Osgood, Jeffery L.

“…This article examines Jim Bulpitt's seminal work on UK territorial politics within the American context. We approach territorial politics by examining the ebbs…”
Get full text

FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer by Royce, Melanie, Osgood, Christy L, Amatya, Anup K, Fiero, Mallorie H, Chang, C J George, Ricks, Tiffany K, Shetty, Krithika A, Kraft, Jeffrey, Qiu, Junshan, Song, Pengfei, Charlab, Rosane, Yu, Jingyu, King, Kathryn E, Rastogi, Anshu, Janelsins, Brian, Weinberg, Wendy C, Clouse, Kathleen, Borders-Hemphill, Vicky, Brown, Lindsey, Gomez-Broughton, Candace, Li, Zhong, Nguyen, Thuy Thanh, Qiu, Zhihao, Ly, Anh-Thy, Chang, Suyoung, Gao, Tingting, Tu, Chi-Ming, King-Kallimanis, Bellinda, Pierce, William F, Chiang, Kelly, Lee, Clara, Goldberg, Kirsten B, Leighton, John K, Tang, Shenghui, Pazdur, Richard, Beaver, Julia A, Amiri-Kordestani, Laleh

“…On December 16, 2020, the FDA granted regular approval to margetuximab-cmkb (MARGENZA), in combination with chemotherapy, for the treatment of adult patients…”
Get full text

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer by Gao, Jennifer J, Osgood, Christy L, Gong, Yutao, Zhang, Hui, Bloomquist, Erik W, Jiang, Xiling, Qiu, Junshan, Yu, Jingyu, Song, Pengfei, Rahman, Nam Atiqur, Chiu, Haw-Jyh, Ricks, Tiffany K, Rizvi, Fatima, Hou, Sherry, Wilson, Willie, Abukhdeir, Abde M, Seidman, Jeffrey, Ghosh, Soma, Philip, Reena, Pierce, William F, Bhatnagar, Vishal, Kluetz, Paul G, Pazdur, Richard, Beaver, Julia A, Amiri-Kordestani, Laleh

“…On June 29, 2020, the FDA approved pertuzumab, trastuzumab, and hyaluronidase-zzxf subcutaneous injection (Phesgo) for the treatment of patients with…”
Get full text

FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer by Gao, Jennifer J, Osgood, Christy L, Feng, Zhou, Bloomquist, Erik W, Tang, Shenghui, Chang, C J George, Ricks, Tiffany K, Hou, Sherry C, Pierce, William F, Rivera, Donna R, Pazdur, Richard, Kluetz, Paul G, Amiri-Kordestani, Laleh

“…On December 10, 2021, the FDA expanded the indications for ribociclib to include male patients for the treatment of hormone receptor-positive, HER2-negative…”
Get full text

Hyperchloremia, not Concomitant Hypernatremia, Independently Predicts Early Mortality in Critically Ill Moderate–Severe Traumatic Brain Injury Patients by Ditch, Kristen L., Flahive, Julie M., West, Ashley M., Osgood, Marcy L., Muehlschlegel, Susanne

“…Background Hypernatremia has been associated with mortality in neurocritically ill patients, with and without traumatic brain injury (TBI). These studies,…”
Get full text

U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review by Arora, Shaily, Narayan, Preeti, Ison, Gwynn, Berman, Tara, Suzman, Daniel L, Wedam, Suparna, Prowell, Tatiana M, Ghosh, Soma, Philip, Reena, Osgood, Christy L, Gao, Jennifer J, Shah, Mirat, Krol, Danielle, Wahby, Sakar, Royce, Melanie, Brus, Christina, Bloomquist, Erik W, Fiero, Mallorie H, Tang, Shenghui, Pazdur, Richard, Ibrahim, Amna, Amiri-Kordestani, Laleh, Beaver, Julia A

“…Over the last decade, there has been tremendous progress in the treatment of patients with gynecologic cancers with a changing therapy landscape. This summary…”
Get full text

Improving Access to Specialist Palliative Care for Patients With Catastrophic Strokes Using Best Practice Advisory- a Feasibility Study by Nagpal, Vandana, Osgood, Marcey L., Reidy, Jennifer, Healy, Rose, Silver, Brian

“…Background and Purpose The American Heart Association and American Stroke Association (AHA/ASA) strongly recommend specialty palliative care (PC) for all…”
Get full text

Sonographic features of drug-induced splenic congestion by O'Brien, R.T, Waller, K.R. III, Osgood, T.L

“…Drug‐induced splenic congestion has been reported in dogs secondary to barbiturate administration. This research attempted to verify and quantify size changes…”
Get full text

The Role of Citizen Participation and the Use of Social Media Platforms in the Participatory Budgeting Process by Gordon, Victoria, Osgood, Jeffery L., Boden, Daniel

“…In the United States participatory budgeting (PB) is a relatively new and innovative approach to municipal budgeting that has implications for improving the…”
Get full text

Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor by Osgood, Christy L, Maloney, Nichole, Kidd, Christopher G, Kitchen-Goosen, Susan, Segars, Laura, Gebregiorgis, Meti, Woldemichael, Girma M, He, Min, Sankar, Savita, Lessnick, Stephen L, Kang, Min, Smith, Malcolm, Turner, Lisa, Madaj, Zachary B, Winn, Mary E, Núñez, Luz-Elena, González-Sabín, Javier, Helman, Lee J, Morís, Francisco, Grohar, Patrick J

“…The goal of this study was to identify second-generation mithramycin analogues that better target the EWS-FLI1 transcription factor for Ewing sarcoma. We…”
Get full text

The utility of FDG-PET in the preoperative staging of esophageal cancer by Gananadha, S., Hazebroek, E. J., Leibman, S., Berry, H., Osgood, L., Shon, I. Ho, Pavlakis, N., Marx, G., Smith, G. S.

“…Accurate staging of esophageal cancer is important when determining which patients will potentially benefit from curative surgery. The aim of this study was to…”
Get full text